Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tarsus Pharmaceuticals (TARS) Inventory (2023 - 2025)

Historic Inventory for Tarsus Pharmaceuticals (TARS) over the last 3 years, with Q3 2025 value amounting to $3.8 million.

  • Tarsus Pharmaceuticals' Inventory rose 3478.57% to $3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.8 million, marking a year-over-year increase of 3478.57%. This contributed to the annual value of $2.6 million for FY2024, which is 1567.43% down from last year.
  • Latest data reveals that Tarsus Pharmaceuticals reported Inventory of $3.8 million as of Q3 2025, which was up 3478.57% from $3.9 million recorded in Q2 2025.
  • Over the past 5 years, Tarsus Pharmaceuticals' Inventory peaked at $4.0 million during Q1 2024, and registered a low of $15000.0 during Q3 2023.
  • Moreover, its 3-year median value for Inventory was $2.8 million (2024), whereas its average is $2.8 million.
  • Per our database at Business Quant, Tarsus Pharmaceuticals' Inventory soared by 1887333.33% in 2024 and then plummeted by 3297.82% in 2025.
  • Tarsus Pharmaceuticals' Inventory (Quarter) stood at $3.1 million in 2023, then decreased by 15.67% to $2.6 million in 2024, then soared by 46.41% to $3.8 million in 2025.
  • Its Inventory was $3.8 million in Q3 2025, compared to $3.9 million in Q2 2025 and $2.7 million in Q1 2025.